Prospective Study to Validate the Clinical Accuracy of the Norbert Device to Measure Oxygen Saturation

Healthy Clinical Trial

Official title:

Prospective Study to Validate the Clinical Accuracy of the Norbert Device to Measure Oxygen Saturation

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05685654
• Other study ID #: NCP-0003
• Status: Not yet recruiting
• Start date: March 2023
• Est. completion date: March 2023

Study information

• Verified date: January 2023
• Source: Norbert Health
• Contact: Ellie Gonzalez
• Phone: 503-400-17222
• Email: ellie[@]norberthealth.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to evaluate the SpO2 accuracy and performance of the Norbert Device during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-oximetry for SpO2 validation.

Description:

The study is a single center, prospective, non-randomized study to measure the accuracy of an investigational device compared to blood reference values. The design of the study will be conducted in accordance with the recommendations of ISO 80601-2-61:2011 Annex EE.2 Procedure for invasive laboratory testing on healthy volunteers. The purpose of this study is to evaluate the SpO2 accuracy and performance of the Norbert Device during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-oximetry for SpO2 validation. The end goal is to show the SpO2 accuracy performance of the Norbert Device. It is expected that the Accuracy Root Mean Square (Arms) performance of pulse oximeters will meet a specification of 3.5 or better in non-motion conditions for the range of 70-100% SaO2 thereby demonstrating an acceptable SpO2 accuracy performance specification.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 15
• Est. completion date: March 2023
• Est. primary completion date: March 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Healthy, male or female subjects between the ages of 18 to 50 years

• Completion of a health screening for a medical history by a licensed physician, nurse practitioner, or physician assistant

• Previously measured hemoglobin electrophoresis with normal result recorded in Duke Epic EHR

• Minimum weight 40kg; BMI within range 18.0 - 35.0

• Assigned American Society of Anesthesiologists (ASA) Physical Status 1 by Principal Investigator or delegate

Exclusion Criteria:

• Prior or known allergies to lidocaine (or similar pharmacologic agents, e.g., Novocain)

• Prior known severe allergies to medical grade adhesive/tape (Band-Aid)

• Taking any medication other than birth control

• Is currently participating in, or has recently participated in (discontinued within 30 days prior to the hypoxia procedure for this study) in an investigational interventional drug, device, or biologic study

• Has a negative Allen's Test to confirm non patency of the collateral artery

• Has made a whole blood donation or has had at least 450 ml of blood drawn within 8 weeks prior to the study procedure

• Is female with a positive urine pregnancy test, or is female and is unwilling to use effective birth control between the time of screening and study procedure or is breast feeding

• Has anemia

• Has heparin allergy

• Has a history of sickle cell trait or thalassemia [self-reported]

• Has a positive urine cotinine test or urine drug screen or oral ethanol test

• Has a room air saturation less than 95% by pulse oximetry

• Has a clinically significant abnormal EKG

• Has a COHb greater than 3%, or MetHb greater than 2%

• Students and Employees under the direct supervision of PI or Sub-I

Related Conditions & MeSH terms

• Healthy
• Hypoxia

Intervention

Device:
• Norbert Device
The Norbert Device (ND) is a contactless, noninvasive device that provides measurements of body temperature, oxygen saturation (SpO2), and pulse rate.

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Norbert Health	Duke University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	SpO2 root mean square accuracy of the Norbert Device	SpO2 root mean square accuracy will be calculated following FDA guidelines.	Up to 1 hour
Primary	SpO2 bias of the Norbert Device	SpO2 bias calculation of the Norbert Device will follow the FDA guidelines for analyzing population mean bias, between-subject variance, and within-subject variance.	Up to 1 hour
Primary	Bland-Altman plots with linear regression line and 95% upper and lower limits of agreement	A method comparison study will be analyzed with a Bland-Altman plot. This study will produce limits of agreement (LoA) and associated confidence intervals from the two measurements obtained on each subject. The conclusion that the two measurements are in agreement depends on whether the confidence intervals constructed from the data are within the boundaries set from the maximum allowable difference.	Up to 1 hour